Strong Buy
Buy
Hold
Sell
Strong Sell
Consensus
| Date | Grading Company | New Grade | Previous Grade | Action | Price When Posted | News Title | Publisher |
|---|---|---|---|---|---|---|---|
| 2026-10-20 | Piper Sandler | Neutral | Underweight | Upgrade | $5.7613 | Myriad Genetics upgraded to Neutral from Underweight at Pip… | TheFly |
| 2026-10-13 | Cowen & Co. | Hold | Hold | Hold | $4.2 | Myriad Genetics price target raised to $4.50 from $4 at TD … | TheFly |
| 2026-10-02 | Craig-Hallum | Buy | Buy | Hold | $4.3297 | Myriad Genetics price target raised to $8 from $4 at Craig-… | TheFly |
| 2026-09-01 | Piper Sandler | Underweight | Overweight | Downgrade | $3.22 | Myriad Genetics downgraded to Underweight from Overweight a… | TheFly |
| 2026-07-31 | Cowen & Co. | Hold | Hold | Hold | $5.37 | Myriad Genetics price target lowered to $4 from $6 at TD Co… | TheFly |
| 2026-02-24 | UBS | Neutral | Neutral | Hold | $4.38 | Myriad Genetics price target lowered to $6 from $8 at UBS | TheFly |
| 2025-11-04 | Cowen & Co. | Hold | Hold | Hold | $6.65 | Myriad Genetics price target raised to $9 from $8 at TD Cow… | TheFly |
| 2025-11-04 | UBS | Neutral | Neutral | Hold | $8.18 | Myriad Genetics price target raised to $8 from $6 at UBS | TheFly |
| 2025-05-21 | Scotiabank | Sector Perform | Sector Outperform | Downgrade | $4.07 | Scotiabank downgrades Myriad Genetics, sees 'transitional y… | TheFly |
| 2025-05-07 | Craig-Hallum | Buy | Buy | Hold | $7.27 | Myriad Genetics price target lowered to $18 from $29 at Cra… | TheFly |